GlassScriptPhysician profile
Fredrick M Che
NPI 1952539249
$12,928.67
in general payments reported to CMS, 2019-2025
6 companies · $3,044 in 2025
The $3,044 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,341 · 2020: $181 · 2021: $269 · 2022: $1,185 · 2023: $2,778 · 2024: $131 · 2025: $3,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,669 · Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,668.71 |
| Food and Beverage | $284.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,906.37 | 2019-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| W. L. Gore & Associates, INC. | $471.56 | 2019-2023 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Endogastric Solutions, INC | $372.11 | 2021-2024 | Esophyx |
| Apollo Endosurgery US INC | $106.26 | 2019 | |
| Davol INC. | $44.37 | 2025 | Phasix Mesh |
| Sanofi-Aventis U.S. LLC | $28.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredrick Che listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.